Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin
- PMID: 36943002
- PMCID: PMC10228291
- DOI: 10.1093/europace/euad072
Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin
Abstract
Conflict of interest statement
Conflict of interest: None declared.
Comment in
-
Regarding the editorial by Sau and Ng. 'Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin'.Europace. 2023 Jul 4;25(7):euad175. doi: 10.1093/europace/euad175. Europace. 2023. PMID: 37338129 Free PMC article. No abstract available.
-
Response to letter by Saumarez et al. entitled 'Regarding the editorial by Sau and Ng. "Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin"'.Europace. 2023 Jul 4;25(7):euad174. doi: 10.1093/europace/euad174. Europace. 2023. PMID: 37339284 Free PMC article. No abstract available.
Comment on
-
Should lethal arrhythmias in hypertrophic cardiomyopathy be predicted using non-electrophysiological methods?Europace. 2023 May 19;25(5):euad045. doi: 10.1093/europace/euad045. Europace. 2023. PMID: 36942430 Free PMC article.
References
-
- Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 2015;65:1249–54. - PubMed
-
- Maron BJ. Clinical course and management of hypertrophic cardiomyopathy. N Eng J Med 2018;379:655–68. - PubMed
-
- Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott Pet al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol 2020;76:3022–55. - PubMed
-
- Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron Pet al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2733–79. - PubMed
-
- Maron BJ, Casey SA, Chan RH, Garberich RF, Rowin EJ, Maron MS. Independent assessment of the European Society of Cardiology sudden death risk model for hypertrophic cardiomyopathy. Am J Cardiol 2015;116:757–64. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
